Methylene Blue Spray for Identification of Recurrent Laryngeal Nerve and Parathyroid Gland

Zagazig University

Status: Completed

Conditions: Methylene Blue; Recurrent Laryngeal Nerve Injuries; Parathyroid Gland

Treatments: Diagnostic Test: methylene blue identification

Study type: Interventional

Funder types: Other

Identifiers

NCT05113628

Methylene blue

Details and patient eligibility

About

Thyroidectomy is the procedure by which surgeons treat various thyroid diseases and is considered the commonest endocrinal surgery. Yet, it carries a risk for intraoperative complications. The most distressing complications are recurrent laryngeal nerve and parathyroid injuries. Methylene blue spray is a technique than can be used for easy identification of both recurrent laryngeal nerve and parathyroid glands so we can avoid their injuries.

Full description

Thyroid disorders constitute the second most common endocrine disease following diabetes mellitus. Thyroid surgery is one of the most frequently operated Head and Neck surgeries. Post-thyroidectomy complications are not uncommon. Parathyroids and Recurrent Laryngeal Nerve (RLN) are two of the complications of thyroidectomy that cause significant postoperative morbidity Due to the advances in thyroids surgeries, the occurrence of postoperative complications has been decreased, but when occurred, they cause lifelong handicap. The most important complications encountered are injury to the RLN and parathyroids. Meticulous dissection is a key factor in minimizing the occurrence of complications During thyroidectomy, careful dissection can protect the parathyroid glands and RLN. Various methods were used including capsular dissection, attention to protection of the arterial supply to parathyroids, avoiding unnecessary manipulation in the area of RLN Methylene blue spraying is a new technique that allows identification of both parathyroid glands and recurrent laryngeal nerves

Enrollment: 80 patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age of 16 years and older.
• Both sexes.
• Patients who are candidate for thyroid surgery and euthyroid.

Exclusion criteria

• • Patients with hyper- or hypo-thyroid status.
• Patients who were unfit for surgery.
• Patients with unilateral or bilateral vocal cord palsy on preoperative indirect laryngoscopy
• Patients with thyroid malignancy by preoperative FNAC.
• Patients with hypersensitivity to methylene blue were excluded.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

80 participants in 2 patient groups

anatomical identification

No Intervention group

Description:

thyroidectomy was done with identification of both RLN and parathyroid gland done on anatomical basis

methylene blue identification

Sham Comparator group

Description:

thyroidectomy was done with identification of both RLN and parathyroid gland done using methylene blue spray (0.5 ml methylene blue 2% was diluted by 5ml normal saline) was sprayed over the lower thyroid pole and the perilobar area

Treatment:

Diagnostic Test: methylene blue identification